组蛋白变体H3.3 L27M突变与胶质瘤发生

组蛋白变体在基因表达等基本细胞过程中发挥重要调节功能。人类有5种H3变体,分别为H3.1、 H3.2、H3.3、着丝粒特异性CENP-A和睾丸特异性H3t。人H3.3有H3F3A和H3F3B两个基因编码。采用DNA全基因组测序的方法在儿童高级别胶质瘤如恶性胶质瘤（GBM）和弥漫性内在脑桥胶质瘤（DIPG）鉴定出高频的H3F3A突变。超过70%DIPG和30%GBM携带H3.3 K27M氨基酸错义突变（27位赖氨酸被甲硫氨酸代替）。H3.3 K27M通过与组蛋白H3K27甲基转移酶EZH2亚基相互作用而抑制多梳抑制复合物2（PRC2）活性并全面减少H3K27me3含量。因此H3.3 K27M突变重塑了表观修饰状态和基因表达模式,从而驱动肿瘤发生。K27M突变可作为分子标志物以更好区分儿童胶质瘤亚型,还可作为特异、敏感的预后标志物。通过抑制组蛋白去甲基化酶如JMJD3活性而增加H3K27甲基化可作为K27M突变胶质瘤治疗的有效策略。本文综述了组蛋白变体H3.3 K27M在胶质瘤中的突变模式、分子机制和临床应用。     

源于小孢子培养的大麦耐盐变异体获取

以大麦品种‘花30’作为供试材料,比较了甲基磺酸乙酯（EMS）和平阳霉素处理小孢子60Co γ-射线辐照处理离体穗和干种子,对300mg·L-1NaCl胁迫培养下游离小孢子的愈伤组织产量和愈伤组织在0.3％NaCl胁迫筛选下的绿苗产量的影响。结果表明,EMS处理离体小孢子和60Co γ-射线辐照千种子的愈伤组织产量和绿苗产量明显优于平阳霉素处理小孢子和60Co γ-射线辐照离体穗。以16份源于种子辐照处理的再生植株自交一代种子为供试材料,比较了在0．3％NaCl胁迫下种子的发芽率和幼苗的成活率以及植株的分蘖数、株高和单株产量。结果表明,‘花30’发芽率为0,供试的16份耐盐变异体中,有14份材料在NaCl胁迫下的发芽率优于‘花30’,鉴定出4份耐盐性明显优于‘花30’的变异体材料。选择耐盐变异体作为供试材料,测定了变异体中Na＋／H＋逆向转运蛋白基因NHXl、NHX2和NHX3和编码甜菜碱醛脱氢酶（BADH）的两个同工酶基因曰肋,和BBD2的表达模式和表达量,结果表明变异体耐盐性的提高与这些基因的表达量存在联系。     

水稻高脯氨酸愈伤组织变异体盐胁迫下氨基酸和蛋白质组分的变化

游离氨基酸组分分析表明,水稻培养细胞中谷氨酸和丙氨酸含量很高,占氨基酸总量的４０％。高脯氨酸愈伤组织变异体总游离氨基酸含量比原型高４５．５％,其中脯氨酸增加最多,其次是雨氨酸和谷氨酸。当ＮａＣｌ１００ｍｍｏｌ／Ｌ处理时变异体和原型的总氨基酸都增加,而变异体的增量约为原型增量的３倍。蛋白水解氨基酸组分中变异体和原型各氨基酸的相对含量无大差异。蛋白质双向电泳表明,高脯氨酸变异体的蛋白组分发生变化,明显比原型多４个蛋白点。在ＮａＣｌ１００ｍｍｏｌ／Ｌ处理下原型亦产生５３．３ｋＤ蛋白,变异体中该蛋白的含量变得更多。盐胁迫下变异体和原型的蛋白质组分变化的差异十分显著,主要表现在蛋白质等电点的变化不同。     

长非编码RNA PVT1与消化系统肿瘤

长非编码RNA（long non-coding RNAs, lncRNAs）在肿瘤发生、发展进程中承担重要角色,是近年来的研究热点之一。大量研究表明,浆细胞瘤变异易位基因1（plasmacytoma variant translocation 1, PVT1）可通过多种分子机制参与调控消化系统肿瘤的增殖凋亡、迁移侵袭、细胞自噬、血管生成、多药耐药及肿瘤代谢等过程,从而发挥致癌作用。本文主要就PVT1在消化系统肿瘤中的表达水平变化,及其与临床病理特征和预后的关系,以及PVT1对消化系统肿瘤的致癌作用机制和多药耐药机制等研究进展作一综述。     

关于HCMV 潜伏感染与激活感染研究的新进展

人巨细胞病毒(HCMV)是疱疹病毒科中最大的病毒,结构复杂,其感染在人群中非常普遍,近年来免疫妥协(immunocompromised)群体尤其是移植群体中的HCMV潜伏感染和激活感染越来越受到临床重视。本文就HCMV的感染与免疫、HCMV的致病机制、宿主的抗感染与免疫、HCMV的免疫逃逸、HCMV的潜伏与激活及HCMV相关研究的困境与展望近年来此方面研究新进展作一简要综述。     

Serological properties of Abiotrophia and Granulicatella species (nutritionally variant streptococci)

Serological variations were examined among 12 type or reference strains and 91 oral isolates of vitamin B6-dependent Abiotrophia and Granulicatella spp. Rabbits were immunized with whole cells of 12 selected strains and 10 typing antisera were obtained, which were unreactive with the Lancefield group A to G antigen preparations. The reactivity of the antisera and autoclaved cell surface antigen extracts was tested by double diffusion in agar gel and a capillary precipitin test. These typing antisera categorized all Abiotrophia defectiva strains, all except one Granulicatella elegans strain, three-quarters of the Granulicatella adiacens, and half of the Granulicatella paraadiacens into 8 serotypes and 2 subserotypes. The Granulicatella balaenopterae type strain was unserotypable. All A. defectiva strains were serotype I, some of which were divided into subserotype I-1 and/or I-5. The G. adiacens strains generally belonged to serotype II or III, and the G. paraadiacens strains to serotype IV, V or VI. All G. adiacens or G. paraadiacens serotype II strains were also subserotype I-5. The G. elegans strains were serotype VII or VIII. These Abiotrophia and Granulicatella serotypes were undetectable among 33 strains of the other 11 species including the bacteriolytic enzyme-producing but vitamin B6-independent strains of Streptococcus, Enterococcus, Dolosigranulum and Aerococcus. The proposed serotyping system for Abiotrophia and Granulicatella spp. would be helpful in the identification and classification of these unique coccal isolates in ecological and epidemiological studies.     

药蒲公英(Taraxacum officinale Weber)耐1.5% NaCl变异体的筛选及特性分析

为提高药蒲公英的耐盐性, 用20~30 d大小的药蒲公英叶片诱导愈伤, 获得的愈伤以NaCl作为选择因子, 用直接筛选的方法, 每3周进行一次继代培养, 经3个月继代筛选获得了耐1.5% NaCl的药蒲公英愈伤组织, 将耐1.5% NaCl的药蒲公英愈伤组织接种在分化培养基上分化出芽, 之后将再生芽转接到生根培养基中进行生根培养, 经4个月得到了12株耐1.5% NaCl的药蒲公英再生植株。与野生型相比, 耐盐植株叶片宽大、叶柄粗短、叶表面覆盖白色细毛, 根粗壮较短, 花茎中部具2 cm左右的苞叶。RAPD(Random amplified polymorphic DNA , 随机扩增的多态性DNA)和SDS-PAGE检测表明, 耐盐植株与对照植株在DNA及蛋白水平上均存在明显差异。1.5% NaCl处理后, 与普通再生植株相比, 耐盐株系的抗氧化酶活性明显提高, 脯氨酸含量上升幅度更为显著, 而丙二醛(MDA)含量降低, 其主要药用成分黄酮的含量显著增加。这些结果说明耐盐植株的抗氧化防御能力明显增强。以上结果表明耐1.5% NaCl的药蒲公英再生植株为耐1.5% NaCl药蒲公英变异体, 这些耐盐变异体有望成为抗盐耐海水蔬菜家族的新成员。同时, 这些耐盐变异体植株比普通植株具有更高的医用商业价值。耐1.5% NaCl的药蒲公英再生变异体遗传稳定性的研究正在进行中。     

Use of a non-volatile thiocarbamate to select for herbicide-tolerant tobacco cell lines

A method is described for using the non-volatile thiocarbamate R-14705 (S-3-methylpyridyl N,N-di-butyl-thiocarbamate) to select for herbicide-tolerant tobacco in cell culture. Properties of two selected cell lines are described. Both lines were stably resistant to R-14705 in the absence of continuous selection, and showed significant cross-resistance to commercial thiocarbamate herbicides. The concept of using analogs to solve problems caused by physical properties of a potential selective agent is discussed.     

Tumour escape: antitumour effectors too much of a good thing?

Although even spontaneous tumours are immunogenic and are commonly infiltrated by tumour antigen-specific T cells (at least in melanoma), most tumours are not completely rejected by the host, and cancer progresses. There is a growing realisation that many responses defined as antitumour effector mechanisms act as double-edged swords and under different conditions either become ineffective or even protumorigenic. Examples are interleukin 2 (also proapoptotic for activated T cells), interferon (by induction of ligands for T and NK cell inhibitory receptors), angiogenesis inhibition (by hypoxia-mediated induction of growth factors promoting metastasis), and macrophage free radical-mediated cytotoxicity (by inhibiting T cells). Immune selection pressure itself, resulting in outgrowth of resistant tumour variants could also be viewed in this light. On the other hand, knowledge of the many tumour escape pathways offers the theoretical possibility of reconstituting antitumour immunity. Tumour escape from immunosurveillance represents the last series of hurdles to be overcome in formulating truly effective cancer immunotherapy, but given the immense plasticity of the tumour cell, and the complex balance between pro- and antitumour activity of the very same effector pathways, this remains a major challenge.This article is based on presentations made at the first Cancer Immunology and Immunotherapy Summer School, 8–13 September 2003, Ionian Village, Bartholomeio, Peloponnese, Greece.     

Cloning and identification of two novel splice variants of human PD-L2

T cell activation is dependent upon signals deliveredthrough the antigen-specific T cell receptors and costimula-tory molecules [1,2]. The B7 family of costimulatory mol-ecules provides signals that are critical for both stimula-ting and inhibiting T cell…